Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ATAI Life Sciences N.V. - Common Shares (NQ:ATAI)

6.420 -0.030 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ATAI Life Sciences N.V. - Common Shares

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
28 29 Next >
Psychedelic Stock Gainers And Losers From February 24, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
 
Via Benzinga
"Rags-To-Riches" Portfolio Underperforming YTD
The munKNEE 
Via Talk Markets
Wall Street Thinks These 2 Penny Stocks Could Go Parabolic
Wall Street is bullish on these two beaten-down healthcare stocks. 
Via The Motley Fool
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
A look at the performance of the six largest psychedelic stocks by market capitalization. 
Via Talk Markets
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
 
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
 
Via Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Major Psychedelic Compound-Based Stocks UP 13% YTD
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances. 
Via Talk Markets
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 8, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 7, 2023
 
Via Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
The 7 Most Promising Psychedelic Stocks to Buy in February
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector. 
Via InvestorPlace
6 Largest Psychedelic Stocks Down 3% This Week
The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From February 3, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 2, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 1, 2023
 
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
The "Rags-To-Riches" Portfolio Update: Week Ending January 27
The Rags-to-Riches Portfolio tracks the performance of 14 cannabis, psychedelic and plant-based food stocks constituent . Here, performances last week and year-to-date. 
Via Talk Markets
Top 3 Psychedelic Storylines To Watch In 2023
This article by James Hallifax was originally published on Microdose and appears here with permission. 
Via Benzinga
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD
We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results. 
Via Talk Markets
Cybin, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.